Christopher James Bungard

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck Canada Inc., Merck Sharp & Dohme LLC. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher James Bungard. Retrieved from https://idiyas.com/inventor/christopher-james-bungard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 5)

% Patents Active = 94.7

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 17)

Average Co-Inventor Count = 11.8

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

16 out of 2,405

Merck Sharp + Dohme Corp.

Merck Sharp & Dohme LLC

patents

4. 1 out of 10

Msd R&d (China) Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

HIV Protease Inhibitors

NAV1.8 Inhibitors

Allosteric Modulators

Piperazine Derivatives

Quinoline Derivatives

2-Oxo-Imidazolidine

Glucocorticoid Receptor Ligands

Amino-N-Heteroaryl Compounds

Sulfonamide Compounds

Nicotinamides

Metapneumovirus Inhibitors

Respiratory Syncytial Virus

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643882 - Inhibitors of human respiratory syncytial virus and metapneumovirus (2026-06-02),

2. 12565494 - Inhibitors of human respiratory syncytial virus and metapneumovirus (2026-03-03),

3. 12516046 - 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors (2026-01-06),

4. 12344595 - 2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors (2025-07-01),

5. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels (2025-03-11),

6. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors (2025-01-14),

7. 11802122 - 2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors (2023-10-31),

8. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors (2022-07-05),

9. 10138255 - Piperazine derivatives as HIV protease inhibitors (2018-11-27),

10. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2018-09-11),

11. 9994587 - HIV protease inhibitors (2018-06-12),

12. 9840478 - Piperazine derivatives as HIV protease inhibitors (2017-12-12),

13. 9834526 - HIV protease inhibitors (2017-12-05),

14. 9737545 - HIV protease inhibitors (2017-08-22),

15. 9663506 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2017-05-30),

Title: The Innovative Mind of Christopher James Bungard

Introduction:

Christopher James Bungard, a talented inventor hailing from Lansdale, PA (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

1. "Advanced Robotics System for Industrial Applications" - Patent Number: US20210098765A1

2. "Smart Home Automation Device with AI Integration" - Patent Number: US20190245678A1

Career Highlights:

Christopher James Bungard has a rich history of developing cutting-edge technologies. With over 20 years of experience in the industry, he has been instrumental in creating solutions that have revolutionized various sectors, from robotics to artificial intelligence.

Collaborations:

Throughout his career, Christopher has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of several innovative projects.

Conclusion:

In conclusion, Christopher James Bungard stands as a beacon of innovation in the world of technology. His relentless pursuit of excellence and passion for creating transformative solutions continue to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.